Companies /Healthcare

Upstream Bio, Inc.

NASDAQ: UPB Biotechnology
$6.19
▲ $0.18 (+3.00%) today
Markets closed · 4:36am ET
Today · % change

Fundamentals

Market Cap
$329.2M
Revenue (TTM)
$3.2M
EPS (TTM)
$-2.88
52-Week Range
$6 – $34
Street Target
$31.14

About Upstream Bio

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. The company is headquartered in Waltham, Massachusetts.

UPB Coverage